Studies have shown that use of automated bolus advisor technology among insulin pump users facilitates accurate determination of prandial insulin dosages, reduces postprandial excursion, and reduces hypoglycaemia, leading to improved glycaemic control [18,19]. The gene discussed is INS; the disease is Hypoglycemia.